Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Loganville Comprehensive Treatment Ctr in Loganville, GA, provides outpatient services for addiction and substance abuse in adults and young adults, including detoxification. Their treatment methods incorporate anger management, brief intervention, and cognitive behavioral therapy. The center caters to specific groups with specialized programs for active military personnel, adult males, and adult females. They emphasize personalized treatment strategies to offer thorough assistance to every individual. Loganville Comprehensive Treatment Ctr is recognized for its dedication to high-quality care and scientifically validated methods, establishing it as a reliable option for individuals pursuing successful recovery from addiction.
Situated in Hampton Bays, NY, Long Island Center for Recovery Inc delivers exceptional treatment for substance use within a residential framework. The center offers a holistic approach to care utilizing methods such as 12-step facilitation, the Matrix Model, and strategies for relapse prevention. It features specialized programs designed for active duty military personnel, as well as for adult men and women, addressing a range of personal needs. Catering to both adults and young adults of all genders, Long Island Center for Recovery Inc prioritizes personalized care and customized support. Clients can anticipate effective, evidence-informed treatment in a nurturing atmosphere that promotes healing and recovery.
Long Island Center for Recovery Inc, situated in Hampton Bays, NY, delivers a full spectrum of addiction treatment. Specializing in detoxification and addressing substance use disorders, the center features hospital inpatient detoxification, round-the-clock hospital inpatient care, and residential detoxification. Employing proven methods such as 12-step facilitation, the Matrix Model, and relapse prevention, they serve active duty military members and adult men and women of all ages. Gender-specific programming guarantees a personalized approach to recovery. Discover effective treatment and dedicated support at Long Island Center for Recovery Inc.
Long Island Jewish Medical Center in Glen Oaks, NY, provides extensive addiction recovery support. This center offers outpatient detox, treatment for substance use issues, and specialized care for those with co-occurring mental health conditions in adults or emotional challenges in youth. Their treatment strategies incorporate brief intervention, cognitive behavioral therapy, and motivational interviewing. The facility also features distinct programs for adult men and women, and for individuals with a history of trauma. Serving both adults and young adults, Long Island Jewish Medical Center delivers personalized, high-quality care for all genders.
Nestled in Metairie, LA, Longbranch Recovery and Wellness is dedicated to assisting those on their journey toward overcoming substance use disorders. Their holistic approach encompasses detoxification services, comprehensive substance use treatment, and tailored support for individuals of all ages facing the complexities of dual diagnoses. Longbranch Recovery and Wellness provides a spectrum of outpatient care, including intensive programs, general outpatient services, and outpatient detoxification. Utilizing proven therapeutic modalities like 12-step facilitation, anger management, and cognitive behavioral therapy, they foster healing. Dedicated programs are available for individuals with co-occurring mental health and substance use conditions, offering personalized support for adults and young adults, irrespective of gender. Discover effective care and dedicated assistance at Longbranch Recovery and Wellness.
Longbranch Recovery Center, situated in Abita Springs, LA, delivers all-encompassing support for adults and young adults facing challenges with addiction and coexisting psychological concerns. This establishment features hospital-based inpatient detoxification and therapeutic interventions, complete with tailored offerings for adult males and individuals managing dual diagnoses. Emphasizing 12-step program integration, emotional regulation strategies, and cognitive-behavioral techniques, Longbranch Recovery Center customizes recovery journeys to suit each person's unique situation. Through fostering a nurturing atmosphere and utilizing scientifically validated methods, this center guarantees superior assistance for both male and female individuals pursuing freedom from dependency.
Situated in Chicago, IL, Loretto Hospital provides a wide range of rehabilitation services aimed at adults and young adults dealing with substance use disorders, alongside co-occurring mental health issues. This establishment focuses on hospital inpatient detoxification and offers treatment with round-the-clock supervision, employing methods like brief intervention, relapse prevention, and counseling for substance use disorders. With customized programs for adult men, women, and those who have faced intimate partner or domestic violence, Loretto Hospital is committed to delivering individualized support for every patient. Their specialized care for all genders among adults and young adults highlights their dedication to comprehensive healing and recovery.
At Lott Behavioral Health in Lisle, IL, we provide complete outpatient care for those striving for sobriety from addiction and dual diagnoses. Our programs are tailored for adults managing significant mental health challenges and children with emotional concerns. Emphasizing a personal approach, Lott Behavioral Health employs proven methods like CBT and 12-step guidance. We offer outpatient detox and MAT using methadone, buprenorphine, or naltrexone, serving all genders and ages. Discover excellent, customized support at Lott Behavioral Health.
Lotus Center Inc. in Moorhead, MN, delivers a complete spectrum of addiction treatment solutions, crafted to address unique personal circumstances. They provide structured outpatient care, ongoing outpatient support, and accommodations for those transitioning back into independent living. Employing techniques such as cognitive behavioral therapy, motivational interviewing, and relapse prevention tactics, the center emphasizes a thorough path to recovery. Their custom-designed programs cater to adults and young adults, regardless of gender. Lotus Center Inc. distinguishes itself through its dedication to high-standard care and bespoke recovery strategies, serving as a crucial provider of effective and encouraging rehabilitation assistance.
Lost River Treatment Center, located in Wyandotte, OK, provides outpatient detox services along with treatment for substance use and mental health disorders affecting both adults and children with emotional challenges. Their offerings encompass anger management, cognitive-behavioral therapy, and motivational incentives. Catering to adults and young individuals of all genders, the facility emphasizes a tailored approach to care. With a commitment to high-quality support, Lost River Treatment Center is recognized for its extensive outpatient programs and specialized care for individuals with dual diagnoses. If you are looking for personalized and impactful addiction recovery options, this center is committed to guiding you toward wellness.
Local NP PC, situated in La Salle, IL, stands as a premier facility dedicated to outpatient care for individuals facing substance use challenges. The center offers comprehensive treatment for adults, notably including those who are also managing serious mental health conditions. Through evidence-based methodologies like brief intervention, motivational interviewing, and relapse prevention, Local NP PC delivers specialized support. The center features customized programs designed for active military members, adult men, and women. In addition to its regular outpatient services, Local NP PC provides methadone, buprenorphine, or naltrexone treatment. The facility is committed to delivering excellent, personalized care to adults and young adults of all genders, fostering their journey toward recovery and improved well-being.
Situated in Redlands, California, Loma Linda University provides extensive addiction recovery programs tailored for both adults and adolescents. This center offers inpatient detoxification and treatment within a hospital setting, concentrating on the challenges posed by simultaneous substance use and significant mental health issues. Employing research-backed methods like 12-step support, cognitive-behavioral therapy, and short-term interventions, the facility is equipped to meet the distinct needs of active military members as well as adult men and women. With an emphasis on high-quality care and personalized treatment strategies, Loma Linda University stands out as a reliable option for individuals pursuing successful rehabilitation.
Affiliated with Meharry Medical College in Nashville, TN, this center treats adolescents and adults across residential detox, residential care, intensive outpatient, and regular outpatient settings. Buprenorphine and naltrexone are used, and co-occurring serious mental illness is addressed. SAMHSA block grants, federal funding, and payment assistance support affordability.
Lockport Recovery Center offers intensive and regular outpatient treatment in Lockport, New York, with buprenorphine and naltrexone. Programs serve adolescents, pregnant and postpartum women, veterans, military families, and people with HIV or AIDS, alongside care for co-occurring serious mental illness. Medicare, Medicaid, TRICARE, and private insurance are accepted.
This Longwood, Florida, outpatient program combines detoxification with buprenorphine treatment for opioid use disorder. It serves adults including pregnant women, veterans, and people with co-occurring mental, pain, or HIV-related conditions. Medicare, Medicaid, private insurance, and self-pay are accepted.
Los Angeles IOP Center Inc in Burbank, California focuses on intensive outpatient and partial hospitalization care with buprenorphine and naltrexone, treating adults with co-occurring serious mental illness. Programs cover pregnant women, veterans, military families, and trauma survivors. Private insurance, self-pay, state-financed plans, and payment assistance are accepted.
Lotus Behavioral Health Teen Treatment Center in Winter Springs, Florida, treats children and adolescents with substance use and co-occurring mental disorders through partial hospitalization, intensive outpatient, regular outpatient, and short-term residential care. Buprenorphine and naltrexone are used. TRICARE, private insurance, and tribal funds are accepted.
Long Beach Reach Inc, located in Long Beach, NY, provides targeted interventions and assistance for adults contending with concurrent serious mental health conditions alongside substance use disorders. Their outpatient services employ proven therapeutic modalities, including cognitive behavioral therapy and motivational incentives. This center is dedicated to personalized care, serving adults and seniors across all genders. Long Beach Reach Inc offers a full spectrum of services designed to foster recovery, whether an individual requires intensive outpatient care or medication-assisted treatment. For anyone needing customized assistance with both substance use and mental health challenges, this establishment offers empathetic support and successful treatment solutions.
Long Island Consultation Center Inc, located in Elmhurst, NY, provides extensive outpatient services for adults facing substance use challenges alongside mental health conditions. The center focuses on specialized interventions such as anger management, cognitive behavioral therapy, and brief treatments, catering to adult men, women, and adolescents. With a commitment to personalized care, the facility offers distinct programs for both adults and younger clients. In addition to traditional outpatient support, Long Island Consultation Center Inc delivers methadone, buprenorphine, and naltrexone therapies, ensuring effective support for clients of all genders in their journey towards recovery from addiction and mental health difficulties.
Situated in Chicago, IL, the Loren Half Robinson Foundation delivers targeted services for addiction recovery. This center offers detox and treatment options, including intensive outpatient programs and outpatient detox services. Emphasizing 12-step support, anger management, and brief intervention, it serves both men and women, including individuals who have faced issues related to domestic violence. Catering to adults and young adults, the foundation is committed to providing high-quality care and personalized treatment strategies to assist clients in their recovery journey.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.